Literature DB >> 8986312

Subjective muscle weakness and hypotonia during clozapine treatment.

C Galletly1.   

Abstract

Four cases of patients who described an unpleasant subjective experience of weakness and reduced muscle tone during treatment with clozapine are presented. An exacerbation of muscular dystrophy during clozapine treatment is also described. It is hypothesized that these adverse effects are related to the muscle relaxant properties of clozapine. The differential diagnosis of sedation, fatigue, asthenia, and reduced muscle tone is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986312     DOI: 10.3109/10401239609147758

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  2 in total

1.  Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial.

Authors:  Anne C La Flamme; David Abernethy; Dalice Sim; Liz Goode; Michelle Lockhart; David Bourke; Imogen Milner; Toni-Marie Garrill; Purwa Joshi; Eloise Watson; Duncan Smyth; Sean Lance; Bronwen Connor
Journal:  BMJ Neurol Open       Date:  2020-07-09

2.  An impaired health related muscular fitness contributes to a reduced walking capacity in patients with schizophrenia: a cross-sectional study.

Authors:  Davy Vancampfort; Michel Probst; Amber De Herdt; Rui Manuel Nunes Corredeira; Attilio Carraro; Dirk De Wachter; Marc De Hert
Journal:  BMC Psychiatry       Date:  2013-01-03       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.